Contineum Therapeutics Inc (CTNM) - News Archive

Expanding Horizons: Contineum Therapeutics Advances Chronic Pain Treatment with New IND AuthorizationContineum Therapeutics, Inc. a clinical-stage biopharmaceutical company, is making significant strides in the realm of...

The development of novel therapeutic agents has become an imperative focus in the biomedical field, particularly for conditions lacking fully effective treatment options. Recent preclinical data published in the Proceed...

Sarah Boyce Appointed to Contineum Therapeutics Board of Directors: Strengthening the Clinical Stage Biopharmaceutical Company s Drug Development StrategiesIn recent news, Contineum Therapeutics, a clinical stage biopha...

Contineum Therapeutics Announces Appointment of Sarah Boyce to Board of Directors SAN DIEGO Contineum Therapeutics, Inc. (Nasdaq: CTNM), a forward-thinking clinical stage biopharmaceutical company, has further solidifie...